TFF1 and TFF3 mRNAs Are Higher in Blood from Breast Cancer Patients with Metastatic Disease than Those without

Table 3

The number and percentage of high and low levels of TFF1 and TFF3 mRNA between non metastatic and metastatic groups (regarding cut-off 0.70).

	Nonmetastatic group; (n=24); No. (%)	Metastatic group; (n=26); No.(%)	p-value
TFF1
High level	0 (0.0)	9 (34.6%)	0.002
Low level	24 (100.0%)	17 (65.4%)
TFF3
High level	4 (16.7%)	12 (46.2%)	0.026
Low level	20(83.3)	14(53.8)

Significant P < 0.05; Fisher’s exact test to show number and percentage of their high and low expression between studied groups.